 GERMANTOWN, Md.--BUSINESS WIRE--Senseonics Holdings, Inc. NYSE American: SENS a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring CGM systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, 2022 at 3:00pm ET. Interested parties can access a live and recorded 